ASX 200 opens in red as COVID-19 variant Omicron spooks investors


  • The ASX 200 index fell over 1.1% to 7,201.7 in early trade.
  • The World Health Organization (WHO) had classified Omicron variant as "a variant of concern”.
  • The financial space, A-REITs and energy sectors have all taken a hit of more than 1% each.

The Australian share market fell sharply at the open on Monday, extending losses from Friday, as investors made an abrupt exit from riskier assets over the concerns of a threat to economic recovery from the Omicron variant of coronavirus, detected in New South Wales. The ASX 200 index fell over 1.1% to 7,201.7 in early trade.

The World Health Organization (WHO) on Friday made a cautious decision and designated the new coronavirus variant detected in South Africa, having a large number of mutations, as being "a variant of concern”. It is the fifth variant to be designated under this category.

Stock market chart

Image Source: © Embe2006 |

Shares nosedived on Wall Street on Friday soon after the opening, while European stocks witnessed their biggest sell-off in 17 months as the European Union and Britain tightened their borders. Crude oil also plunged by a massive US$10 per barrel or over 11% as fears over the new COVID-19 variant sent investors fleeing to safe-haven assets.

On Friday, the Dow Jones and S&P 500 suffered their biggest one-day percentage drops in many months. The Dow Jones ended 2,53% lower at 34,899.35, while the S&P 500 fell 2.27% to 4,594.61. The NASAQ Composite ended the session 2.23% lower at 15,491.66.

Read More: Omicron rattles oil prices; 3 ASX energy shares to watch out for

How has the market performed so far?

As of 11:00 AM AEDT, the ASX 200 had witnessed a recovery and was trading 0.35% down at 7,253, compared to over a 1.1% fall at the open. The ASX All Ordinaries index was down 0.44% or 33.2 points to 7,566.7.

Top 5 ASX gainers and losers

Data Source: ASX Website (as of 26 November 2021, 11:00 AM AEDT)

Travel stocks took a heavy beating, with Flight Centre Travel Group Limited (ASX:FLT) falling 3.56%,  Webjet Limited (ASX:WEB) dropping 4.67% lower and Qantas Airways Limited (ASX:QAN) falling 2.3%. The top two losers of the ASX 200 were Unibail-Rodamco-Westfield Limited (ASX:URW) and Vicinity Centres (ASX:VCX), both falling 6.99% and 5.62%, respectively.

A few stocks trying to keep the markets from falling were Healius Limited (ASX:HLS) and Domino’s Pizza Enterprises Limited (ASX:DMP), both gaining 3.58% and 3.24%, respectively.

Coming to the market breadth, extremely bearish sentiments led nine out of the 11 sectors into the red zone. The financial space, A-REITs and energy sectors have all taken a hit of more than 1% each. The IT and mining sectors are holding their ground with a 0.48% and 0.4% gain, respectively.


  1. Senex Energy Limited (ASX:SXY)
  • The management has provided POSCO International with a two-week extension period to its exclusivity period.
  • The extension period is regarding a proposal from POSCO to acquire 100% stake in Senex Energy.
  • POSCO had requested this additional period to receive the required internal and board approvals.
  1. Energy Technologies Limited (ASX:EGY)
  • In an AGM presentation, the company said its access to raw materials has been restricted due to limited capital.
  • It has also experienced a decline in orders in relation to COVID-19 through 1H FY21.
  • In the short term, the company is re-structuring its framework of the operational business to save AU$1.4 million.
  1. FirstWave Cloud Technology Limited (ASX:FCT)
  • In an investors’ presentation, the company said the acquisition of Opmantek would be a transformational transaction for FCT.
  • The company has proposed to acquire Opmantek for a total of AU$14 million.
  • It will add more than AU$3.4 million in annualised recurring revenue at 100% margin.
  1. Matrix Composites & Engineering Limited (ASX:MCE)
  • The company has planned to raise AU$7 million in two tranches.
  • It will issue a total of 43.8 million shares at an offer price of AU$0.16 million.
  • The majority of the proceeds (approx. AU$6 million) would be used towards supporting the working capital.
  1. ResApp Health Limited (ASX:RAP)
  • RAP’s Smartphone-only cough counter application has been approved as a medical device in Australia and Europe.
  • The app tracks cough frequency using only a smartphone, using the company’s proprietary machine learning algorithms.
  • ResApp’s technology is already in use by AstraZeneca to monitor disease in a clinical trial.

Read More: These are 5 most shorted ASX-listed shares





Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK